Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-02 18:48:12 - browse：54822

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Burning questions about Delta and the next phase of the Covid pandemic

focus

WSS

Humana CEO Bruce Broussard to step down in 2024

Better Therapeutics data on benefit with GLP

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

How doctors and nurses shape Google's AI

How clinical AI models' predictive power can degrade over time

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

knowledge

Wikipedia

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

State Dept. review finds Biden bears some blame for Afghanistan failures

Akero's treatment for NASH falls short in cirrhosis study

Medical records are filled with copy

Humana CEO Bruce Broussard to step down in 2024

Activists slam private health insurers over coverage restrictions

There’s no way to know how good AI health technologies are

Tori Bowie and the unacceptable rates of Black maternal death

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

entertainment

How doctors and nurses shape Google's AI

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

STAT Readout: Today's biotech news includes Sana and Amylyx

Better Therapeutics data on benefit with GLP

What's changing in Medicare's open enrollment this year?

Female surgeons have lower rates of long

explore

hotspot

focus

leisure time